about
Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccinesProbing lipase/esterase libraries for lipid A hydrolases--discovery of biocatalysts for the detoxification of bacterially-expressed recombinant protein.Binding interactions of bacterial lipopolysaccharide and the cationic amphiphilic peptides polymyxin B and WLBU2.The thermostable direct hemolysin from Grimontia hollisae causes acute hepatotoxicity in vitro and in vivo.Usefulness of ELISA Methods for Assessing LPS Interactions with Proteins and Peptides.Putting on the brakes: Bacterial impediment of wound healing.Optimized Triton X-114 assisted lipopolysaccharide (LPS) removal method reveals the immunomodulatory effect of food proteins.Zwitterionic chitosan for the systemic treatment of sepsis.LPS-protein aggregation influences protein partitioning in aqueous two-phase micellar systems.Marine compounds with therapeutic potential in gram-negative sepsis.Polyclonal antibodies for specific detection of tobacco host cell proteins can be efficiently generated following RuBisCO depletion and the removal of endotoxins.Polyspecificity of Anti-lipid A Antibodies and Its Relevance to the Development of Autoimmunity.Inactivation of Escherichia coli endotoxin by soft hydrothermal processing.Homologous high-throughput expression and purification of highly conserved E coli proteins.Intermediate purification of CHO-derived recombinant human Factor IX using hydrophobic interaction membrane-based chromatography and its comparison to a sulfated resin.Preparation of PVA/amino multi-walled carbon nanotubes nanocomposite microspheres for endotoxin adsorption.Single-use membrane adsorbers for endotoxin removal and purification of endogenous polysialic acid from Escherichia coli K1.Recent advances in nanomedicine for sepsis treatment.Endotoxin removal and prevention for pre-clinical biologics production.Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2).History and current status of polymyxin B-immobilized fiber column for treatment of severe sepsis and septic shock.Chromatographic Removal of Endotoxins: A Bioprocess Engineer's Perspective
P2860
Q28294355-72119CCA-8954-4327-B9FE-5124C41C27F1Q33197502-1F21B386-FFD2-48CA-9C8A-85B4A993150DQ33959844-3FF20FC1-E2C1-4AE8-9794-D520B8A18071Q34598436-BC8148C5-F7C6-4C99-B04A-6131F116278BQ36036386-C6477A65-84AF-4F31-B14B-9B65C17323EEQ36293244-1070130E-72DC-4863-B178-9CE18076D236Q36326711-562CE878-0435-49BB-94FD-3BCC63B7F8E6Q37093311-3A01C985-CEED-4429-91FB-0DDFFADFBF6CQ38103789-BBF3FD6C-7043-4EAF-913B-6FF20CEB3500Q38115689-391319A4-A30F-46DF-BA4A-E58A462DFCA3Q38935868-40AA1303-0C8A-4FBC-837B-335B5E860B16Q40059466-D025BBDF-63A5-4C86-B733-6B55F1923C57Q40387526-5DD6ECF6-B2B5-4226-A1F7-F118953B99B1Q42279848-C3093A0C-7012-43A8-81FB-62D47499ED2DQ47719455-0BAD5318-A986-4542-B621-C3A7ABD77B38Q50780546-C9612C4C-9A13-48AE-BA25-F29EB8027327Q52355064-EB637B39-5F2E-4358-973F-461424DFA72FQ54222088-80D0224D-B867-47CD-BCA9-42401A464703Q54325302-C300AD1A-EC5A-45F3-BDCB-18F3C746634AQ55233846-2A50BC0B-EDA4-404F-AA05-40583641F922Q55260685-7B0F5E5D-77D1-42EA-9970-462F25E68219Q58691968-1CCF352F-CCE9-4D36-A620-5277904BDFEA
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Endotoxin removal by affinity sorbents.
@ast
Endotoxin removal by affinity sorbents.
@en
Endotoxin removal by affinity sorbents.
@nl
type
label
Endotoxin removal by affinity sorbents.
@ast
Endotoxin removal by affinity sorbents.
@en
Endotoxin removal by affinity sorbents.
@nl
prefLabel
Endotoxin removal by affinity sorbents.
@ast
Endotoxin removal by affinity sorbents.
@en
Endotoxin removal by affinity sorbents.
@nl
P1476
Endotoxin removal by affinity sorbents.
@en
P2093
Anspach FB
P304
P356
10.1016/S0165-022X(01)00228-7
P577
2001-10-01T00:00:00Z